Stock ACW ACTINOGEN MEDICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Actinogen Medical Limited

Equities

ACW

AU000000ACW3

Biotechnology & Medical Research

Delayed Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
0.03 AUD +3.45% Intraday chart for Actinogen Medical Limited +3.45% +36.36%
Apr. 22 Actinogen Medical Limited Announces the Full Enrolment of 167 Participants in the Company's XanaCIDD Phase 2A Clinical Trial in Patients with Cognitive Importive in Major Depressant Disorder CI
Apr. 22 Actinogen Medical Completes Patient Enrolment for XanaCIDD Phase 2a Trial; Shares Up 3% MT

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 11.19 24.56 215.9 89.78 72.65 69.81 -
Enterprise Value (EV) 1 3.556 19.91 215.9 73.58 64.19 71.7 123.1
P/E ratio -1.11 x -4.58 x -46.4 x -9.09 x -6.67 x -3.75 x -1.88 x
Yield - - - - - - -
Capitalization / Revenue 2.3 x 6.8 x - 24.4 x 13.8 x 9.07 x 3.44 x
EV / Revenue 0.73 x 5.51 x - 20 x 12.2 x 9.31 x 6.06 x
EV / EBITDA -0.39 x -4.07 x - -8.09 x -6.29 x -4.34 x -3.49 x
EV / FCF - - - - -7.35 x -3.61 x -2.4 x
FCF Yield - - - - -13.6% -27.7% -41.7%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 1,119,231 1,116,231 1,660,559 1,795,644 1,816,252 2,326,921 -
Reference price 2 0.0100 0.0220 0.1300 0.0500 0.0400 0.0300 0.0300
Announcement Date 8/16/19 8/26/20 8/30/21 8/25/22 8/30/23 - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025
Net sales 1 4.863 3.61 - 3.681 5.255 7.7 20.3
EBITDA 1 -9.049 -4.889 - -9.092 -10.21 -16.54 -35.22
EBIT 1 -9.403 -5.302 - -9.492 -10.62 -16.06 -35.45
Operating Margin -193.36% -146.84% - -257.86% -202.08% -208.55% -174.63%
Earnings before Tax (EBT) 1 -9.888 -5.331 - -9.497 -10.75 -16.65 -38.18
Net income 1 -9.888 -5.331 -3.915 -9.497 -10.75 -16.65 -38.18
Net margin -203.33% -147.64% - -258% -204.63% -216.21% -188.08%
EPS 2 -0.009000 -0.004800 -0.002800 -0.005500 -0.006000 -0.008000 -0.0160
Free Cash Flow 1 - - - - -8.735 -19.85 -51.38
FCF margin - - - - -166.23% -257.84% -253.08%
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 8/16/19 8/26/20 8/30/21 8/25/22 8/30/23 - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2023 S1
Net sales 1 1.14
EBITDA -
EBIT 1 -7.345
Operating Margin -644.28%
Earnings before Tax (EBT) -
Net income 1 -7.439
Net margin -652.51%
EPS -
Dividend per Share -
Announcement Date 2/22/23
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - 1.89 53.3
Net Cash position 1 7.64 4.65 - 16.2 8.46 - -
Leverage (Debt/EBITDA) - - - - - -0.1142 x -1.512 x
Free Cash Flow 1 - - - - -8.73 -19.9 -51.4
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - 0.02 - 0 0.04 0.67 1.08
Capex / Sales - 0.63% - 0.08% 0.7% 8.73% 5.33%
Announcement Date 8/16/19 8/26/20 8/30/21 8/25/22 8/30/23 - -
1AUD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Actinogen Medical Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ACTINOGEN MEDICAL LIMITED Stock Actinogen Medical Limited
+36.36% 45.52M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ACW Stock
  4. Financials Actinogen Medical Limited